Mahito Fukui

Director/Miembro de la Junta en C&O Pharmaceutical Technology (Holdings) Ltd. .

Consumer Services

Health Technology

Perfil

Mahito Fukui is currently an Executive Director at C&O Pharmaceutical Technology (Holdings) Ltd.
He completed his undergraduate and graduate degrees at Kwansei Gakuin University in 1995 and 1997 respectively.
He also obtained an MBA from Aoyama Gakuin University in 2005.

Cargos activos de Mahito Fukui

Empresas	Cargo	Inicio
C&O Pharmaceutical Technology (Holdings) Ltd. C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong.	Director/Miembro de la Junta	01/03/2019

Todos los cargos activos de Mahito Fukui

Formación de Mahito Fukui.

Kwansei Gakuin University	Undergraduate Degree
Aoyama Gakuin University	Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mahito Fukui.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
C&O Pharmaceutical Technology (Holdings) Ltd. C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong.	Health Technology